AVNS Stock Analysis: Buy, Sell, or Hold?
AVNS - Avanos Medical, Inc.
$13.32
0.43 (3.34%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
23d
Get Alerted When AVNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 3.7% growth. Moderate conviction.
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 3.7% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.13
Based on 4.8% avg growth
INTRINSIC VALUE TODAY
$9.40
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVNS is currently trading at $13.32, which is considered extended relative to its 30-day fair value range of $11.43 to $12.87. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.0) compared to its historical average (12.6). At these levels, the market is pricing in 3.7% annual earnings growth.
Technical Outlook: Technically, AVNS is in a uptrend. The price is approaching resistance at $13.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: AVNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AVNS is in a uptrend. The price is approaching resistance at $13.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: AVNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$11.43 -
$12.87
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
71.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- NEUTRAL: Near Wall St target ($14.00)
- BULLISH: Expecting earnings turnaround to 3.7% growth with 4.3% revenue growth
Fair Price Analysis
30-Day Fair Range
$11.43 -
$12.87
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$0.72
(5.4%)
Support & Resistance Levels
Support Level
$12.12
Resistance Level
$13.45
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
14.02
Wall Street Target
$14.00
(+5.1%)
Revenue Growth (YoY)
4.3%
Earnings Growth (YoY)
-37.5%
Profit Margin
-67.0%
Valuation Premium vs History
+3.7% premium
PE vs Historical
14.0 vs 12.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.7%
(market-implied from PE analysis)
1-Year Target
$13.81
(+4%)
2-Year Target
$14.32
(+8%)
3-Year Target
$14.85
(+12%)
3-Yr Target (if PE normalizes)
(PE: 14→13)
PE COMPRESSION
$13.35
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 5.6%)
$24.92
(+87%)
Base:
(SPY PE: 14.0, Growth: 5.6%)
$15.67
(+18%)
Bear:
(PE: 11.9, Growth: 5.6%)
$13.32
(0%)
Last updated: February 01, 2026 5:09 PM ET
Data refreshes hourly during market hours. Next update: 6:09 PM
Data refreshes hourly during market hours. Next update: 6:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVNS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gary Blackford
BUY
20000 shares
2025-08-13
Gary Blackford
BUY
40000 shares
2025-08-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
